Talentwolf.co, a prominent recruiter reviews platform, recently announced raising an impressive $42,800,000 in funding. Founded on the mission to revolutionize the recruiting industry, Talentwolf.co offers a comprehensive platform for recruiters worldwide. This significant funding will further enhance the platform's capabilities, enabling them to provide even more valuable recommendations, rankings, and reviews for both hiring managers and job seekers. Through a combination of user feedback, data-driven insights, and performance metrics, Talentwolf.co aims to streamline the recruitment process, making it easier for hiring managers to find top-tier recruiters and for job seekers to connect with the right professionals in their desired field or location. This funding injection will fuel the company's growth and innovation efforts, ensuring that Talentwolf.co continues to be a game-changer in the recruitment industry.
Talentwolf Secures $42.8 Million in Series B Funding to Revolutionize Recruiter Reviews Platform
Recently funded 路 $42.8M Series bRecruitment
Get the full Talentwolf company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
